Tomato Nutrient Complex (15 or 30 mg lycopene) significantly reduced mean systolic blood pressure in untreated hypertensive individuals, unlike lower doses or synthetic lycopene alone.
RCT
Double-blind
Randomized
Does Tomato Nutrient Complex reduce mean systolic blood pressure in untreated hypertensive individuals?
Tomato Nutrient Complex standardized for at least 15 mg of lycopene significantly reduces systolic blood pressure in untreated hypertensive individuals, unlike synthetic lycopene alone.
Oxidative stress is implicated in the pathogenesis of essential hypertension, a risk factor for cardiovascular morbidity and mortality. Tomato carotenoids such as lycopene and the colorless carotenoids phytoene and phytofluene induce the antioxidant defense mechanism. This double-blind, randomized, placebo-controlled study aimed to find effective doses of Tomato Nutrient Complex (TNC) to maintain normal blood pressure in untreated hypertensive individuals. The effect of TNC treatment (5, 15 and 30 mg lycopene) was compared with 15 mg of synthetic lycopene and a placebo over eight weeks. Results indicate that only TNC treatment standardized for 15 or 30 mg of lycopene was associated with significant reductions in mean systolic blood pressure (SBP). Treatment with the lower dose standardized for 5 mg of lycopene or treatment with 15 mg of synthetic lycopene as a standalone had no significant effect. To test carotenoid bioavailability, volunteers were treated for four weeks with TNC providing 2, 5 or 15 mg lycopene. The increase in blood levels of lycopene, phytoene, and phytofluene was dose dependent. Results suggest that only carotenoid levels achieved by the TNC dose of 15 mg lycopene or higher correlate to a beneficial effect on SBP in hypertensive subjects while lower doses and lycopene alone do not.
Wolak et al. (Fri,) conducted a rct in Essential hypertension. Tomato Nutrient Complex (TNC) vs. 15 mg synthetic lycopene and placebo was evaluated on Mean systolic blood pressure (SBP). Tomato Nutrient Complex (15 or 30 mg lycopene) significantly reduced mean systolic blood pressure in untreated hypertensive individuals, unlike lower doses or synthetic lycopene alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: